Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 17451-17500 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03041688
Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia
PHASE1
Active, not recruiting
58 participants
Started: Feb 8, 2018 · Completed: Jun 30, 2026
4 conditions
1 sponsor
13 locations
NCT03872921
norUrsodeoxycholic Acid vs Placebo in PSC
PHASE3
Active, not recruiting
303 participants
Started: Feb 8, 2018 · Completed: Jun 30, 2026
1 condition
1 sponsor
2 locations
NCT03257761
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
PHASE1
Active, not recruiting
55 participants
Started: Feb 7, 2018 · Completed: Dec 31, 2025
28 conditions
3 sponsors
3 locations
NCT03456674
LaseMD System for the Treatment of Melasma
NA
Active, not recruiting
10 participants
Started: Feb 7, 2018 · Completed: Jun 30, 2019
1 condition
1 sponsor
1 location
NCT03283917
Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis
PHASE1
Active, not recruiting
21 participants
Started: Feb 7, 2018 · Completed: May 18, 2027
3 conditions
3 sponsors
1 location
NCT03369106
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
N/A
Active, not recruiting
120 participants
Started: Feb 6, 2018 · Completed: Feb 5, 2026
1 condition
1 sponsor
1 location
NCT03374085
A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)
PHASE1/PHASE2
Active, not recruiting
201 participants
Started: Feb 6, 2018 · Completed: Jan 31, 2028
1 condition
1 sponsor
54 locations
NCT03061539
Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature
PHASE2
Active, not recruiting
380 participants
Started: Feb 6, 2018 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT03225664
Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced
PHASE1/PHASE2
Active, not recruiting
37 participants
Started: Feb 3, 2018 · Completed: Dec 31, 2025
10 conditions
2 sponsors
2 locations
NCT07044791
Metabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast Cancer
NA
Active, not recruiting
120 participants
Started: Feb 2, 2018 · Completed: Feb 2, 2026
2 conditions
1 sponsor
1 location
NCT03462888
Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old Patients
N/A
Active, not recruiting
113 participants
Started: Feb 2, 2018 · Completed: Dec 31, 2024
1 condition
5 sponsors
20 locations
NCT03433911
FemBloc® Permanent Contraception - Early Pivotal Trial
NA
Active, not recruiting
240 participants
Started: Feb 2, 2018 · Completed: Jul 31, 2025
1 condition
1 sponsor
12 locations
NCT03279094
Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
PHASE1
Active, not recruiting
11 participants
Started: Feb 2, 2018 · Completed: Feb 24, 2026
1 condition
1 sponsor
1 location
NCT03495635
Randomized Controlled Trial of Big Brothers Big Sisters Mentoring for Prevention of Crime and Delinquency
NA
Active, not recruiting
1,361 participants
Started: Feb 2, 2018 · Completed: Jun 30, 2025
2 conditions
5 sponsors
1 location
NCT03377023
Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer
PHASE1/PHASE2
Active, not recruiting
66 participants
Started: Feb 2, 2018 · Completed: Nov 30, 2025
3 conditions
1 sponsor
1 location
NCT03647306
Behavioral Chronotype: Impact on Sleep and Metabolism
NA
Active, not recruiting
200 participants
Started: Feb 2, 2018 · Completed: Jan 1, 2027
2 conditions
3 sponsors
1 location
NCT03459170
Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant
PHASE1
Active, not recruiting
15 participants
Started: Feb 1, 2018 · Completed: Sep 30, 2035
1 condition
1 sponsor
3 locations
NCT06642714
Early Non-invasive Ventilation and Progressive High Flow Oxygen Therapy Through Tracheostomy Tube Weaning Protocol in Tracheostomized Patients with Prolonged Mechanical Ventilation
NA
Active, not recruiting
100 participants
Started: Feb 1, 2018 · Completed: Oct 30, 2024
2 conditions
1 sponsor
1 location
NCT05123014
Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease
NA
Active, not recruiting
45 participants
Started: Feb 1, 2018 · Completed: Feb 1, 2027
1 condition
1 sponsor
1 location
NCT03472820
Methylation Diet and Lifestyle Study
NA
Active, not recruiting
44 participants
Started: Feb 1, 2018 · Completed: Dec 31, 2024
3 conditions
3 sponsors
1 location
NCT04565743
Stop At One Stockholm (SAOS)- Secondary Fracture Prevention Through Active Patient Identification and Staff Education.
NA
Active, not recruiting
3,600 participants
Started: Feb 1, 2018 · Completed: Jun 30, 2027
3 conditions
2 sponsors
1 location
NCT03193801
PARTNER 3 Trial - Mitral Valve in Valve
NA
Active, not recruiting
53 participants
Started: Feb 1, 2018 · Completed: Aug 31, 2031
4 conditions
1 sponsor
12 locations
NCT06611904
The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria
NA
Active, not recruiting
60 participants
Started: Feb 1, 2018 · Completed: Dec 15, 2024
3 conditions
1 sponsor
1 location
NCT03424525
11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
PHASE1
Active, not recruiting
30 participants
Started: Feb 1, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03534726
Edema and Fibrosis CMR Imaging in Cardiomyopathy
N/A
Active, not recruiting
13 participants
Started: Feb 1, 2018 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT03113487
P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
PHASE2
Active, not recruiting
29 participants
Started: Feb 1, 2018 · Completed: May 4, 2026
3 conditions
2 sponsors
1 location
NCT03367702
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
PHASE3
Active, not recruiting
692 participants
Started: Feb 1, 2018 · Completed: Dec 1, 2027
1 condition
2 sponsors
293 locations
NCT02073708
A Population-based Investigation of Asthma in the Telemark Region of Norway
N/A
Active, not recruiting
2,000 participants
Started: Feb 1, 2018 · Completed: Dec 31, 2035
3 conditions
4 sponsors
1 location
NCT03431896
Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis
N/A
Active, not recruiting
30 participants
Started: Feb 1, 2018 · Completed: Dec 31, 2026
7 conditions
1 sponsor
1 location
NCT03393039
Effects of Negative Affect in Individuals With Binge Eating Episodes
NA
Active, not recruiting
410 participants
Started: Feb 1, 2018 · Completed: Jun 30, 2026
4 conditions
3 sponsors
1 location
NCT03362554
Identification of New Biomarkers of Insulin Resistance
NA
Active, not recruiting
30 participants
Started: Feb 1, 2018 · Completed: Jan 31, 2028
4 conditions
2 sponsors
1 location
NCT03260920
Intranasal Oxytocin for Frontotemporal Dementia
PHASE2
Active, not recruiting
112 participants
Started: Jan 31, 2018 · Completed: Dec 31, 2024
1 condition
4 sponsors
11 locations
NCT03537976
Targeting Surgeons' Decision-Making for Cleft Lip Surgery
NA
Active, not recruiting
48 participants
Started: Jan 31, 2018 · Completed: Aug 31, 2025
2 conditions
7 sponsors
2 locations
NCT03309332
AMPLATZER PFO Occluder Post Approval Study
NA
Active, not recruiting
1,214 participants
Started: Jan 31, 2018 · Completed: Feb 5, 2030
2 conditions
1 sponsor
89 locations
NCT03401385
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
PHASE1
Active, not recruiting
890 participants
Started: Jan 31, 2018 · Completed: Jan 1, 2027
3 conditions
3 sponsors
18 locations
NCT03392246
A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
PHASE2
Active, not recruiting
25 participants
Started: Jan 31, 2018 · Completed: Jun 30, 2026
1 condition
2 sponsors
4 locations
NCT03328273
A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
PHASE1
Active, not recruiting
12 participants
Started: Jan 31, 2018 · Completed: Aug 26, 2026
1 condition
1 sponsor
11 locations
NCT03424915
Exercise, Fitness and Tumor Profiling in Breast Cancer Patients
N/A
Active, not recruiting
42 participants
Started: Jan 31, 2018 · Completed: Jan 31, 2026
1 condition
1 sponsor
7 locations
NCT03368963
TAS102 in Combination With NAL-IRI in Advanced GI Cancers
PHASE1/PHASE2
Active, not recruiting
64 participants
Started: Jan 30, 2018 · Completed: Nov 28, 2025
14 conditions
3 sponsors
3 locations
NCT02881242
Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer
PHASE2
Active, not recruiting
14 participants
Started: Jan 30, 2018 · Completed: Jan 31, 2025
4 conditions
4 sponsors
1 location
NCT03498261
A Prospective Randomized Double Blind Trial to Assess the Effect of a Single Preoperative Dose of Gabapentin on Postoperative Opioid Consumption in Patients Undergoing Rhinoplasty
PHASE1
Active, not recruiting
50 participants
Started: Jan 30, 2018 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT03414684
Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer
PHASE2
Active, not recruiting
78 participants
Started: Jan 30, 2018 · Completed: Jul 30, 2026
1 condition
2 sponsors
10 locations
NCT03333343
Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC
PHASE1
Active, not recruiting
105 participants
Started: Jan 29, 2018 · Completed: Mar 9, 2026
1 condition
1 sponsor
11 locations
NCT03296592
Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)
N/A
Active, not recruiting
71 participants
Started: Jan 29, 2018 · Completed: Dec 30, 2025
1 condition
2 sponsors
1 location
NCT03413423
Post Acute Cardiac Event Smoking (PACES) Study
NA
Active, not recruiting
233 participants
Started: Jan 29, 2018 · Completed: May 30, 2026
2 conditions
5 sponsors
1 location
NCT03386539
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
PHASE3
Active, not recruiting
211 participants
Started: Jan 29, 2018 · Completed: Jan 31, 2024
7 conditions
3 sponsors
25 locations
NCT04246710
Pancreatic Cancer Molecular Sub-classification Using Endoscopic Ultrasound Tissue Core Biopsy Samples
N/A
Active, not recruiting
160 participants
Started: Jan 28, 2018 · Completed: Jun 2, 2024
1 condition
2 sponsors
1 location
NCT03481387
PERCEVAL S Valve Clinical Study for Chinese Registration
NA
Active, not recruiting
61 participants
Started: Jan 26, 2018 · Completed: Feb 25, 2024
2 conditions
1 sponsor
1 location
NCT02965755
Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins
NA
Active, not recruiting
200 participants
Started: Jan 26, 2018 · Completed: Jun 30, 2026
1 condition
4 sponsors
2 locations
NCT04249973
Detection of Metabolite Biomarkers for the Early Diagnosis and Prognosis of Cow's Milk Allergy in Children
N/A
Active, not recruiting
81 participants
Started: Jan 26, 2018 · Completed: Mar 31, 2025
2 conditions
1 sponsor
8 locations
Previous
1
More pages
347
348
349
350
351
352
353
More pages
431
Next